What is Durasal BREATHALER?
Albuterol is used to treat or prevent bronchospasm in patients with asthma, bronchitis, emphysema, and other lung diseases. This medicine is also used to prevent wheezing caused by exercise (exercise-induced bronchospasm).
Albuterol belongs to the family of medicines known as adrenergic bronchodilators. Adrenergic bronchodilators are medicines that are breathed in through the mouth to open up the bronchial tubes (air passages) in the lungs. They relieve cough, wheezing, shortness of breath, and troubled breathing by increasing the flow of air through the bronchial tubes.
This medicine is available only with your doctor's prescription.
Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, albuterol is used in certain patients with the following medical condition:
- Hyperkalemia (too much potassium in the blood).
Durasal BREATHALER indications
As a bronchodilator in the treatment of bronchospasm associated with bronchial asthma, emphysema and chronic bronchitis and other conditions associated with reversible airways obstruction. Durasal BREATHALER also decreases uterine contractility and arrests premature labor.
Uses of Durasal BREATHALER in details
Durasal BREATHALER is used to prevent reversible airways obstruction occurring during asthma, infections of airway passages (bronchitis), lung disorder in which the flow of air to the lungs is blocked (emphysema), and other lung diseases.
Durasal BREATHALER description
Each 200 mcg/dose powder for inhalation solution contains Salbutamol sulphate equivalent to Durasal BREATHALER 200 mcg per metered dose. The dose, which the patient gets through the mouthpiece of the device is Durasal BREATHALER 180 mcg.
It contains lactose monohydrate (milk protein) as excipient.
The Durasal BREATHALER multiple dose powder inhaler contains 200 doses of finely powdered Durasal BREATHALER sulphate mixed in a small quantity of lactose. The amount of drug received by the patient (180 mcg/dose) corresponds to that from Durasal BREATHALER inhalation aerosol. The dose to be inhaled is released from the container by pressing the device between the thumb and forefinger. This is followed by inhalation through the device. As a result, Durasal BREATHALER particles are transferred to their target, the lungs. Use of the Durasal BREATHALER does not require coordination of actuation of the dose and inhalation.
Durasal BREATHALER dosage
Tablet: Adults: Usual Dose: 4 mg or 10 mL (2 tsp) of syrup. If adequate bronchodilation is not obtained, each single dose may be gradually increased to as much as 8 mg or 20 mL (4 tsp) of syrup.
To be taken every 6 or 8 hrs.
In some patients known to be unusually sensitive to β-adrenergic stimulant drugs who obtain adequate relief with 5 mL of syrup, it is advisable to initiate treatment with 5 mL (1 tsp) of syrup 3 or 4 times a day.
Children >12 years: 2-4 mg or 5-10 mL (1-2 tsp) of syrup; 6-12 years: 2 mg or 5 mL (1 tsp) of syrup; 2-6 years: 1-2 mg or 2.5-5 mL (½-1 tsp) of syrup.
Nebulizing Solution: Adults and Adolescents: Usual Dose: The usual initial dose of Durasal BREATHALER by wet inhalation is 2.5-5 mg. Treatment may be repeated up to 4 times daily. In adults, higher dosing up to 40 mg/day can be given under strict medical supervision in hospital for the treatment of severe airway obstruction.
Children up to 12 years: Dosage has not been established. Note: As there may be adverse effects associated with excessive dosing, the dosage or frequency of administration should only be increased on medical advice.
Administration: Durasal BREATHALER 1 mg/mL nebulizing solution for inhalation is given undiluted using a nebulizer, under the direction of a physician. However, if prolonged administration is desired (>10 min), the solution can be diluted with 0.9% sodium chloride solution.
Direction for Dilution/Prolonged Inhalation: Pipette 2.5-5 mL (equivalent to 2.5-5 mg Durasal BREATHALER, as sulfate) of Durasal BREATHALER nebulizing solution from the bottle by using a calibrated medicine dropper provided in the pack. Drop the solution into an electric nebulizer and dilute it with 2-4 mL normal saline solution and start inhalation. Any unused solution in the chamber of the nebulizer must be discarded. Repeat the same procedure every 8 hrs in a 24-hr period.
Durasal BREATHALER interactions
If additional adrenergic drugs are administered to patients using Durasal BREATHALER Easyhaler they should be used with caution to avoid deleterious cardiovascular effects. Patients treated with monoamine oxidase inhibitors or tricyclic antidepressants should be followed clinically in the beginning of Durasal BREATHALER treatment, because the action of Durasal BREATHALER on the vascular system may be potentiated. Beta-blockers eg, propranolol, inhibit the effect of Durasal BREATHALER like that of any other β2-agonists.
The simultaneous administration of xanthines, corticosteroids or potassium excreting diuretics may increase hypokalemia.
Incompatibilities: Not applicable.
Durasal BREATHALER side effects
See also:
What are the possible side effects of Durasal BREATHALER?
Durasal BREATHALER sulfate is generally well tolerated and serious toxic effects are few. The adverse reactions to Durasal BREATHALER sulfate are similar in nature to reactions to other sympathomimetic agents, although the incidence of certain cardiovascular effects is lower with Durasal BREATHALER sulfate. The most frequent adverse reactions to Durasal BREATHALER sulfate are nervousness and tremor. Other reported reactions are headache, tachycardia and palpitations, muscle cramps, insomnia, nausea, weakness and dizziness. Rare cases of urticaria, angioedema, rash and oropharyngeal edema have been reported after the use of Durasal BREATHALER sulfate. The reactions are generally transient in nature and it is usually not necessary to discontinue treatment with Durasal BREATHALER sulfate. Inform the physician of the unwanted effects after administering.
Durasal BREATHALER contraindications
Hyperthyroidism and cardiac disease. Durasal BREATHALER may interact with monoamine oxidase inhibitors and should not be given to patients receiving such treatment or within 14 days after stopping treatment.
Use in pregnancy & lactation: Safety in pregnancy and lactating women has not been established.
Durasal BREATHALER is not indicated for the prevention of premature labor associated with toxemia of pregnancy or ante partum hemorrhage, nor should it be used for threatened abortion during the 1st and 2nd trimesters of pregnancy.
Active ingredient matches for Durasal BREATHALER:
Salbutamol in India.
| Unit description / dosage (Manufacturer) | Price, USD |
| DURASAL BREATHALER Inhaler / 17gm / 1 units (Raptakos Brett & Co.) | $ 0.92 |
| 20 mg x 1's | $ 0.92 |
| Durasal Breathaler 20mg INH / 1 | $ 0.92 |
| DURASAL BREATHALER 100MCG INHALER 1 packet / 17 GM inhaler each (Raptakos Brett & Co Ltd) | $ 0.99 |
| DURASAL BREATHALER MDI 100 mcg x 1 puff x 17g (Raptakos) | $ 0.99 |
| Durasal Breathaler 20mg INH / 1 | $ 0.92 |
| Durasal Breathaler 100mcg Inhaler (Raptakos Brett & Co Ltd) | $ 0.99 |
List of Durasal BREATHALER substitutes (brand and generic names): | |
| DURASAL-CR (Thailand) | |
| Durasal-CR 8mg CAP / 10 (Raptakos, Brett) | $ 0.11 |
| E-Salbutamol (Bangladesh) | |
| Ecosal (Belgium, Bulgaria, Croatia (Hrvatska), Czech Republic, Estonia, Hungary, Latvia, Lithuania, Romania, Serbia, Slovakia) | |
| Ecosal easi-breath (Romania) | |
| Ecosal Easi-Breathe (Latvia) | |
| Ecosal inhaler (Romania) | |
| Ecovent (Switzerland) | |
| Solution; Inhalation; Albuterol Sulfate 0.5% (Ecosol) | |
| Ecutamol (Ecuador) | |
| Efamed (Philippines) | |
| Efamed Plus 100's | |
| Efamed 2 mg/5 mL x 60 mL | |
| Efamed Plus 60 mL | |
| Emplusal (Philippines) | |
| Emplusal 2 mg x 100's (Pharmacare) | $ 4.44 |
| Emplusal 2 mg/5 mL x 60 mL (Pharmacare) | $ 1.91 |
| Éolène (France) | |
| Etinoline (China) | |
| Etinoline 4 mg x 10 x 10's (Ethypharm Industries) | |
| Capsules, Sustained Release; Oral; Albuterol Sulfate 4 mg (Ethypharm Industries) | |
| Etinoline SR cap 4 mg 10 x 10's (Ethypharm Industries) | |
| Etol (Bangladesh, Turkey) | |
| ETOL 800MG TABLET 1 strip / 10 tablets each (Nobel) | $ 0.84 |
| Etol 800mg Tablet (Nobel) | $ 0.08 |
| Eulin (Pakistan) | |
| Exafil (Mexico) | |
| Faktolin (Pakistan) | |
| Farbutamol (Peru) | |
| Farcolin (Bahrain, Georgia, Oman) | |
| Farmarest (Mexico) | |
| Fartolin (Indonesia) | |
| Fartolin 2 mg x 10 x 10's (Fahrenheit) | $ 5.46 |
| Fartolin Expectorant (Indonesia) | |
| Fartolin Expectorant 100 mL x 1's (Fahrenheit) | $ 3.72 |
| Fesema (Chile, Colombia) | |
| Solution; Inhalation; Albuterol Sulfate 5 mg / ml (Etex) | |
| Fesema LF (Chile) | |
| Aerosol, Metered-Dose; Inhalation; Albuterol Sulfate 100 mcg / dose | |
| G-Salbutamol (Bangladesh) | |
| Gen-Salbutamol (Canada) | |
| Solution; Inhalation; Albuterol Sulfate 5 mg / ml | |
| GenRx Salbutamol (Australia) | |
| Injectable; Injection; Albuterol Sulfate 1 mg / ml | |
| Gerivent (Ireland) | |
| Glaxo Salbutamol (India) | |
| Glaxo Salbutamol 100 mcg Inhaler (Glaxo Smithkline Pharmaceuticals Ltd.) | $ 0.00 |
| Glaxo Salbutamol INH (India) | |
| Glaxo Salbutamol INH 100mcg/puff MDI / 200md | $ 1.00 |
| 100 mcg x 1 puff x 200md | $ 1.00 |
| GRACOF PLUS | |
| GRACOF PLUS SYRUP 1 bottle / 100 ML syrup each (GRAF Laboratories Pvt Ltd) | $ 0.57 |
| Grafalin (Indonesia) | |
| Grafalin 2 mg x 10 x 10's | $ 3.06 |
| Grafalin 4 mg x 10 x 10's | $ 3.72 |
| H-Selax (Bangladesh) | |
| Hasalbu (Vietnam) | |
| Hasalbu 2 mg x 1 Bottle 100 Tablet | |
| Hasalbu 2 mg x 5 Blister x 10 Tablet | |
See 1516 substitutes for Durasal BREATHALER | |
References
- DailyMed. "ALBUTEROL: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubChem. "Salbutamol". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
- DrugBank. "Salbutamol". http://www.drugbank.ca/drugs/DB01001 (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Durasal BREATHALER are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Durasal BREATHALER. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yetConsumer reported age
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
